T Cell Lymphomas
LA JOLLA, CALIF. – Hematologists from the Royal Marsden Hospital in London review their best practices for the hardest to treat PTCL cases.
LA JOLLA, CALIF. – The study mines data from the SEER-18 database.
LA JOLLA, CALIF. – The phase 1 trial is testing the use of a CD25 monoclonal antibody for achieving long-term remission in PTCL.
LA JOLLA, CALIF. – Subtype and timing matter when considering the best bridge to transplant.
In 2017, the FDA approved 17 agents for new or expanded indications for hematologic malignancies, including one agent for anaplastic large cell...
LA JOLLA, CALIF. – Three new agents are in the pipeline for T-cell lymphoma.
ATLANTA – Mogamulizumab topped vorinostat in terms of overall response to treatment and on several quality of life scales
Approval was based on a 56% objective response rate for brentuximab vedotin vs. 12% for physician’s choice of methotrexate or bexarotene in a...
From the Journals
Childhood inflammatory bowel disease was associated with significant increases in the risk of cancer in later life.